Sustained activation and tumor targeting of NKT cells using a CD1d–anti-HER2–scFv fusion protein induce antitumor effects in mice

Invariant NKT (iNKT) cells are potent activators of DCs, NK cells, and T cells, and their antitumor activity has been well demonstrated. A single injection of the high-affinity CD1d ligand α-galactosylceramide (αGalCer) leads to short-lived iNKT cell activation followed, however, by long-term anergy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Stirnemann, Kathrin, Romero, Jackeline F., Baldi, Lucia, Robert, Bruno, Cesson, Valérie, Besra, Gurdyal S., Zauderer, Maurice, Wurm, Florian, Corradin, Giampietro, Mach, Jean-Pierre, MacDonald, H. Robson, Donda, Alena
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Clinical Investigation 2008
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2230658/
https://ncbi.nlm.nih.gov/pubmed/18259610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI33249
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge